Government launches AI-powered breast cancer screening trial to improve early detection

The UK government has announced the launch of a large-scale trial designed to evaluate the effectiveness of artificial intelligence (AI) in improving early detection rates of breast cancer. The initiative, led by the Department of Health and Social Care (DHSC), will involve nearly 700,000 individuals undergoing breast cancer screening at 30 sites across England. These locations will be equipped with AI-driven technologies aimed at enhancing the accuracy and efficiency of breast cancer diagnoses.

Harnessing AI to Support Radiologists in Early Detection

Breast cancer remains the most prevalent cancer among women in the UK, with approximately 55,000 people diagnosed each year. Early detection is critical for improving outcomes, and the use of AI has the potential to assist radiologists in identifying subtle changes in breast tissue that may indicate cancer.

The technology will analyse mammograms and flag any abnormalities, allowing healthcare professionals to determine whether further investigation is needed. Currently, two specialists are required to review each mammogram; however, AI integration could enable safe and efficient screening with just one specialist, reducing pressure on radiology teams.

A Major Step Forward in Breast Cancer Screening

Professor Lucy Chappell, Chief Scientific Adviser at the DHSC and Chief Executive of the National Institute for Health and Care Research (NIHR), emphasised the importance of the study, stating:

“This landmark trial could lead to a significant step forward in the early detection of breast cancer, offering women faster, more accurate diagnoses when it matters most.”

She also highlighted the role of the NIHR in advancing medical research:

“It is another example of how NIHR research, shaped and funded by the public, is crucial for rigorously testing world-leading new technologies, such as AI, that can potentially save lives while reducing the burden on the NHS.”

The ‘Early Detection using Information Technology in Health’ (EDITH) trial, backed by £11 million in government funding, aims to determine whether AI can reduce the workload of radiologists while maintaining or improving diagnostic accuracy. If successful, this approach could lead to shorter waiting times, improved patient experiences, and earlier interventions for those at risk.

A National Cancer Plan to Drive Improvements in Care

Alongside the AI trial, the government is also seeking input from people with cancer, healthcare professionals, and researchers to shape a new National Cancer Plan. Health Secretary Wes Streeting launched a call for evidence on World Cancer Day, inviting contributions via the Change NHS online platform.

Streeting, himself a cancer survivor, underscored the urgency of improving cancer care in the UK:

“As a cancer survivor, I feel like one of the lucky ones.”

He acknowledged the challenges posed by rising cancer diagnoses and international comparisons:

“With record numbers of people diagnosed with cancer, and Lord Darzi finding that cancer survival is worse in this country than our peers, I know that urgent action is needed to save lives and improve patient care.”

Streeting also reaffirmed the government’s commitment to developing a world-leading cancer strategy:

“That’s why for World Cancer Day, I am committed to publishing a dedicated national cancer plan this year, to unleash Britain’s potential as a world-leader in saving lives from this deadly disease and make the NHS fit for the future through our Plan for Change.”

The feedback gathered from the public and medical professionals will directly inform the development of the 10-year National Cancer Plan, set to be published later this year.

AI and the Future of Healthcare

This initiative aligns with the government’s broader commitment to leveraging AI for healthcare improvements. The AI Opportunities Action Plan, launched in January 2025, has already attracted over £14 billion in investment, reflecting a strong focus on integrating advanced technology into the NHS.

If the EDITH trial proves successful, AI-powered screening could become a transformative tool in breast cancer detection, leading to earlier diagnoses, improved treatment pathways, and ultimately, better survival rates.With AI revolutionising diagnostics and a new cancer plan in development, the UK is taking decisive steps toward enhancing cancer care and ensuring the NHS remains at the forefront of medical innovation.